The limitation of flowcytometry is ignored in the assessment of antimitochondrial antibodies in rheumatoid arthritis: comment on the article by Moore et al

被引：0
|
作者：
Jearn, La-He [1 ]
Kim, Think-You [2 ]
机构：
[1] Hanyang Univ, Med Ctr, Seoul, South Korea
[2] Hanyang Univ, Coll Med, Seoul, South Korea
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷 / 03期
关键词：
D O I：
10.1002/art.42729
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：488 / 489
页数：2
相关论文
共 50 条
  • [41] Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et al
    Strandberg, Timo E.
    Kovanen, Petri T.
    Eklund, Kari K.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3644 - 3645
  • [42] Severity of rheumatoid arthritis in Portuguese patients: comment on the article by Drosos et al and on the letter by Ronda et al - Reply
    Drosos, AA
    Panayi, GS
    Moutsopoulos, HM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (02): : 471 - 472
  • [43] Galectin 3 as a novel therapeutic target in rheumatoid arthritis: comment on the article by Forsman et al
    Li, Xia
    Zhao, Qing-Yi
    Yuan, Feng-Lai
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3179 - 3180
  • [44] HLA-DMA and DMB genes in rheumatoid arthritis: comment on the article by Pinet et al
    Singal, DP
    Ye, M
    ARTHRITIS AND RHEUMATISM, 1998, 41 (05): : 946 - 947
  • [45] Sleep-related disorders in adults with rheumatoid arthritis: comment on article by Katz et al
    Chen, Chun-Chieh
    Wang, Po-Hui
    Chen, Shiuan-Chih
    ARTHRITIS CARE & RESEARCH, 2023, 75 (12) : 2544 - 2544
  • [46] Response to methotrexate and reduced mortality in patients with rheumatoid arthritis:: comment on the article by Krause et al
    Alarcón, GS
    ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1902 - 1903
  • [47] Anticitrulline antibody assay specificity for rheumatoid arthritis: comment on the article by Schellekens et al - Reply
    Hazes, JMM
    van Venrooij, WJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1902 - 1902
  • [48] Should the definition of clinical remission of rheumatoid arthritis be revised? Comment on the article by Molenaar et al
    Rothschild, B
    ARTHRITIS AND RHEUMATISM, 2004, 50 (10): : 3397 - 3397
  • [49] Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply
    Bresnihan, B
    Alvaro-Gracia, JM
    Cobby, M
    Doherty, M
    Domljan, Z
    Emery, P
    Nuki, G
    Pavelka, K
    Rau, R
    Rozman, B
    Watt, I
    Williams, B
    Aitchison, R
    McCabe, D
    Musikic, P
    ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1782 - 1782
  • [50] Novel approaches to discovery of biomarkers in rheumatoid arthritis: comment on the article by Oswald et al Reply
    Gregersen, Peter K.
    Oswald, Michaela
    Curran, Mark
    Carulli, John
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2277 - 2277
12345